Loading...
Market
First to Develop New H5N1 Vaccine by End of 2025?
2
Resolution / Starting Odds
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Official announcements from pharmaceutical companies and health organizations
Story
Wisconsin Confirms First Human Case of H5N1 Bird Flu in Barron County; National Total Reaches 64 Cases Across 8 States
Dec 20, 2024, 08:11 PM
Wisconsin has confirmed its first human case of H5N1 bird flu, following an individual in Barron County who was exposed to infected poultry at a commercial farm. The case has been verified by the CDC, contributing to a national total of at least 64 confirmed cases across eight states this year. Health officials in Wisconsin received the test results from the CDC, confirming the infection. Additionally, Iowa reported its first human case of bird flu shortly after Wisconsin's confirmation, indicating a growing concern over the spread of H5N1 in the region.
View original story
Similar markets
Pfizer • 25%
Merck • 25%
Zoetis • 25%
Other • 25%
WHO • 25%
CDC • 25%
European Medicines Agency (EMA) • 25%
Other • 25%
GSK • 25%
Sanofi • 25%
CSL • 25%
None by deadline • 25%
GSK • 33%
Sanofi • 33%
Seqirus • 33%
Yes, by a major pharmaceutical company • 25%
Yes, by a government agency • 25%
Yes, by a university or research institution • 25%
No vaccine developed • 25%
Moderna • 25%
Sinergium Biotech • 25%
Pfizer • 25%
Other • 25%
Vaccine approved and in use • 25%
Vaccine in clinical trials • 25%
Vaccine in development but not in trials • 25%
No vaccine development • 25%